# ORINOVA

> nanoparticle-enhanced cancer treatment

Business model and tags: Pharma & life sciences, Has in-house R&D

## About ORINOVA

Development of patented nanomedicine combining chemotherapy and radiotherapy in a targeted nanosphere to treat solid tumors effectively with fewer side effects.

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 1–10 employees
- **Headquarters**: Besançon, Bourgogne-Franche-Comté, France
- **Founded**: 2024
- **Revenue**: €3M – €23.3M (Tamtam estimate)
- **LinkedIn**: [linkedin.com/company/or-inova](https://www.linkedin.com/company/or-inova)

## ORINOVA at a glance

ORINOVA is a company in the Pharmaceutical Manufacturing industry, headquartered in Besançon, Bourgogne-Franche-Comté, France.

ORINOVA was founded in 2024.

ORINOVA has 1–10 employees.

ORINOVA's revenue is €3M – €23.3M (Tamtam estimate).

## Frequently asked questions about ORINOVA

### What is ORINOVA's revenue?

Tamtam estimates ORINOVA's annual revenue at €3M – €23.3M.

### How many employees does ORINOVA have?

ORINOVA has 1–10 employees.

### Where is ORINOVA headquartered?

ORINOVA is headquartered in Besançon, Bourgogne-Franche-Comté, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/orinova